Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
GREB1L has been implicated in autosomal dominant unilateral renal agenesis based on segregation analyses in two independent three-generation pedigrees. In a family with two female cousins presenting with MRKH syndrome and unilateral renal agenesis and two male relatives with renal agenesis, a heterozygous GREB1L c.705G>T (p.Trp235Cys) variant segregated in all four affected individuals, consistent with incomplete penetrance (4 affected) (PMID:31424080). Separately, a novel GREB1L c.4507C>T (p.Arg1503Trp) variant was identified in a three-generation kindred with three members exhibiting unilateral renal hypodysplasia/aplasia, with functional studies demonstrating reduced GREB1L mRNA and protein levels and downstream PAX2 and PTH1R dysregulation (3 affected) (PMID:36371238).
The pedigrees support autosomal dominant inheritance with reduced penetrance. Functional analyses of the c.4507C>T variant confirmed a loss-of-function mechanism through in vitro knockdown and mRNA downregulation. Additional animal model data in zebrafish show renal tract anomalies upon GREB1L disruption, further concordant with the human phenotype. No large-scale case-control studies or recurrent founder variants have been reported to date.
Collectively, the limited number of small pedigrees and preliminary functional data establish GREB1L as a candidate gene for unilateral renal agenesis; however, larger cohorts and mechanistic studies are required for definitive classification.
Key take-home: GREB1L heterozygous loss-of-function variants should be considered in the genetic evaluation of familial unilateral renal agenesis.
Gene–Disease AssociationLimitedTwo pedigrees (4 and 3 affected individuals) segregating heterozygous GREB1L variants; preliminary functional data; no large cohorts Genetic EvidenceLimitedSegregation in two small families (total 7 affected) with heterozygous variants; no unrelated case–control studies Functional EvidenceLimitedIn vitro expression and splicing assays demonstrate mRNA/protein downregulation; animal model data support renal tract anomalies |